Combination of the angiogenesis inhibitor lucitanib with immune checkpoint blockade augments anti-tumor activity in syngeneic models

被引：0
|
作者：
Dusek, Rachel [1 ]
Robillard, Liliane [1 ]
Harding, Thomas [1 ]
Simmons, Andrew [1 ]
Minh Nguyen [1 ]
机构：
[1] Clovis Oncol Inc, San Francisco, CA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P242
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Oncolytic viruses: Potential for in situ anti-tumor vaccination and combination with checkpoint blockade
    Melcher, Alan
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [22] Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors
    Muraro, Elena
    Vinante, Lorenzo
    Fratta, Elisabetta
    Bearz, Alessandra
    Hoefler, Daniela
    Steffan, Agostino
    Baboci, Lorena
    CANCERS, 2023, 15 (09)
  • [23] Obatoclax, the pan-Bcl-2 inhibitor sensitizes hepatocellular carcinoma cells to promote the anti-tumor efficacy in combination with immune checkpoint blockade
    Li, Jingye
    Xu, Jinrong
    Li, Zhibing
    TRANSLATIONAL ONCOLOGY, 2021, 14 (08):
  • [24] RNAi-mediated ß-catenin inhibition promotes T-cell infiltration and anti-tumor activity in combination with immune checkpoint blockade
    Ganesh, Shanthi
    Shui, Serena
    Wang, Weimin
    Brown, Bob D.
    Abrams, Marc
    CANCER RESEARCH, 2017, 77
  • [25] Combination of a DNA vaccine-induced immune checkpoint blockade and radiation therapy induces anti-tumor immunity
    Lan, Keng-Hsueh
    Sheng, Ying-Chun
    Lan, Keng-Li
    Kim, KyungMann
    Kuo, Sung-Hsin
    Morris, Zachary
    CANCER RESEARCH, 2023, 83 (07)
  • [26] Effects of antibiotics on the anti-tumor efficacy of immune checkpoint inhibitor therapy
    Nie, Fangfang
    Guo, Jungang
    Pan, Jiayi
    Guo, Zhaojiao
    Wang, Chun
    Yan, Jun
    Ma, Weina
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, : 790 - 799
  • [27] Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA
    Redmond, William L.
    Kasiewicz, Melissa J.
    Akporiaye, Emmanuel T.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [28] Syngeneic tumor mouse models vary in their response to different immune checkpoint inhibitor treatment
    Jantscheff, P.
    Schaefer-Obodozie, C.
    Moor, S.
    Weber, H.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : S11 - S11
  • [29] Combination of rapamycin with immune checkpoint blockade in a syngeneic breast carcinoma model
    Trachet, Erin
    Elders, Chris
    Urs, Sumithra
    Krueger, Sarah
    Wong, Alden
    Franklin, Maryland Rosenfeld
    CANCER RESEARCH, 2018, 78 (13)
  • [30] Dual immune checkpoint inhibition enhances the anti-tumor activity of trastuzumab deruxtecan in preclinical models
    Jenkins, Liam
    Kazlauskas, Laura
    Wilson, Matt
    Hammond, Scott A.
    Proia, Theresa
    Mettetal, Jerome
    CANCER RESEARCH, 2024, 84 (06)
12345